Grabenhorst et al., 1997 - Google Patents
Construction of novel BHK-21 cell lines coexpressing Golgi resident or soluble forms of human α2, 6-sialyltransferase and α1, 3/4-fucosyltransferases together with …Grabenhorst et al., 1997
- Document ID
- 3173285182406041011
- Author
- Grabenhorst E
- Costa J
- Conradt H
- Publication year
- Publication venue
- Animal Cell Technology: From Vaccines to Genetic Medicine
External Links
Snippet
The most frequently used mammalian host cell lines (BHK-21, CHO) for the production of recombinant therapeutic glycoproteins are incapable of producing α2, 6-sialylated or sialyl Lewis X containing Oligosaccharide structures. Therefore, we have constructed novel stable …
- 102000003886 Glycoproteins 0 title abstract description 33
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/305—Pyrimidine nucleotides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
- C07K14/70564—Selectins, e.g. CD62
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Grabenhorst et al. | Genetic engineering of recombinant glycoproteins and glycosylation pathway in mammalian host cells | |
| Grabenhorst et al. | Construction of Stable BHK‐21 Cells Coexpressing Human Secretory Glycoproteins and Human Gal (β1‐4) GlcNAc‐R α2, 6‐Sialyltransferase: α2, 6‐Linked NeuAc is Preferentially Attached to the Gal (β1‐4) GlcNAc (β1‐2) Man (α1‐3)‐Branch of Diantennary Oligosaccharides from Secreted Recombinant β‐Trace Protein | |
| EP0497878B1 (en) | Method for producing secretable glycosyltransferases | |
| US6284493B1 (en) | Method of synthesizing saccharide compositions | |
| EP1539989B1 (en) | Synthesis of oligosaccharides, glycolipids and glycoproteins using bacterial glycosyltransferases | |
| Watt et al. | Enzyme-catalyzed formation of glycosidic linkages | |
| US20020019342A1 (en) | In vitro modification of glycosylation patterns of recombinant glycopeptides | |
| Rendić et al. | The glycosylation capacity of insect cells | |
| De Vries et al. | Acceptor specificity of GDP-Fuc: Galβ1→ 4GlcNAc-R α3-fucosyltransferase VI (FucT VI) expressed in insect cells as soluble, secreted enzyme | |
| Kawar et al. | Novel poly-GalNAcβ1–4GlcNAc (LacdiNAc) and fucosylated poly-LacdiNAc N-glycans from mammalian cells expressing β1, 4-N-acetylgalactosaminyltransferase and α1, 3-fucosyltransferase | |
| Meynial-Salles et al. | In vitro glycosylation of proteins: an enzymatic approach | |
| Jeong et al. | Enhanced sialylation of recombinant erythropoietin in genetically engineered Chinese‐hamster ovary cells | |
| CA2911965A1 (en) | Process for the mono- and bi-sialylation of glycoproteins employing n-terminally truncated beta-galactoside alpha-2,6-sialyltransferase mutants | |
| US5541083A (en) | Method for producing secretable glycosyltransferases and other golgi processing enzymes | |
| Grabenhorst et al. | Construction of novel BHK-21 cell lines coexpressing Golgi resident or soluble forms of human α2, 6-sialyltransferase and α1, 3/4-fucosyltransferases together with secretory glycoproteins | |
| Broquet et al. | Glycoprotein sialyltransferases in eucaryotic cells | |
| Shinkai et al. | High-level expression and purification of a recombinant human α-1, 3-fucosyltransferase in baculovirus-infected insect cells | |
| Schlenke et al. | Construction and characterization of stably transfected BHK-21 cells with human-type sialylation characteristic | |
| JP2023515554A (en) | Enzymes for sialylation of glycans | |
| Kim et al. | High-level expression of human glycosyltransferases in insect cells as biochemically active form | |
| Schlenke et al. | Expression of human α2, 6-Sialyltransferase in BHK-21A cells increases the sialylation of coexpressed human erythropoietin: NeuAc-transfer onto GalNAc (βl-4) GlcNAc-R motives | |
| Zeng et al. | Pilot scale expression and purification of soluble protein A tagged β1, 6N-acetylglucosaminyltransferase in CHO cells | |
| Clarke | Considerations for glycoprotein production | |
| Al-Amoodi | Expression and Purification of Glycosyltransferases in Pichia Pastoris: Towards Improving the Migration of Stem Cells by Enhancing Surface Expression of Sialyl Lewis X | |
| Grabenhorst et al. | Targeting of Genetically Engineered Glycosyltransferases to In Vivo Functional Golgi Subcompartments of Mammalian Cells |